Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Influenza Vaccinations”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Early research (Phase 1)Study completedNCT06850051
What this trial is testing

A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.

Who this might be right for
Healthy VolunteersInfluenza VaccinationRespiratory Syncytial Virus Vaccination+2 more
Sanofi 270
Post-approval studies (Phase 4)Study completedNCT06020118
What this trial is testing

Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations

Who this might be right for
InfluenzaCOVID-19
Duke University 455
Testing effectiveness (Phase 2)Study completedNCT06727058
What this trial is testing

Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and Older

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 276
Early research (Phase 1)Study completedNCT01059617
What this trial is testing

Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults

Who this might be right for
Influenza
GlaxoSmithKline 133
Testing effectiveness (Phase 2)WithdrawnNCT00342940
What this trial is testing

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

Who this might be right for
Influenza
Novartis
Testing effectiveness (Phase 2)Study completedNCT06890429
What this trial is testing

Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults

Who this might be right for
Respiratory Synctial Virus Infections
Research Institute of Influenza, Russia 120
Not applicableStudy completedNCT01771367
What this trial is testing

Training Study to Characterize Biomarkers to Flu Vaccines

Who this might be right for
Healthy
University of Surrey 49
Testing effectiveness (Phase 2)Study completedNCT06695130
What this trial is testing

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older

Who this might be right for
COVID-19 ImmunizationInfluenza Immunization
Sanofi 980
Testing effectiveness (Phase 2)Study completedNCT06695117
What this trial is testing

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older

Who this might be right for
COVID-19 ImmunizationInfluenza Immunization
Sanofi 980
Early research (Phase 1)Study completedNCT01737580
What this trial is testing

Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists

Who this might be right for
Influenza Vaccination in Seniors
University of British Columbia 59
Testing effectiveness (Phase 2)Study completedNCT05874713
What this trial is testing

Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults

Who this might be right for
Influenza, HumanInfectionsRespiratory Tract Infections+2 more
Seqirus 480
Large-scale testing (Phase 3)Study completedNCT05047770
What this trial is testing

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

Who this might be right for
Herpes Zoster
GlaxoSmithKline 2,013
Post-approval studies (Phase 4)Study completedNCT04551677
What this trial is testing

Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 90
Large-scale testing (Phase 3)Study completedNCT04024228
What this trial is testing

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 1,539
Testing effectiveness (Phase 2)Study completedNCT06582277
What this trial is testing

Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836

Who this might be right for
Vaccine-Preventable DiseasesInfluenza
Osivax 117